| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
R.FGITQAK.V 1.11 13.69 382.7211 43.18 - 53.93 2 1E5 47.08 345 351 N
K.TLNVVLK.T 2.72 60.00 393.7609 62.56 - 67.25 2 1E5 64.59 370 376 N
K.LPESMK.R 0.74 7.89 352.6906 33.15 - 39.90 2 9.4E4 35.93 323 328 N
K.ITWEK.L 0.91 11.10 338.6904 43.18 - 49.60 2 5.9E4 46.05 318 322 N
R.LSDFLSR.Y 1.00 10.89 419.2283 65.95 - 72.30 2 3.6E4 69.30 334 340 N
K.FIYMITK.A 0.85 10.46 458.2647 83.03 - 86.69 2 3.4E4 84.94 413 419 N
K.EYSTEITAETGR.I 0.68 9.74 678.8255 48.82 - 58.12 2 3.2E4 52.00 296 307 N
K.LPESMK.R 0.31 1.60 704.3691 33.94 - 39.73 1 2.8E4 36.40 323 328 N
K.ANAAEC(+57.02)SMVK.D 1.03 13.73 540.7478 34.25 - 39.55 2 2.8E4 35.94 420 429 N Carbamidomethylation
K.ITWEK.L 0.54 9.05 676.3720 43.08 - 49.88 1 2.2E4 46.57 318 322 N
K.RLSDFLSR.Y 0.78 9.60 497.2810 70.72 - 74.40 2 2E4 72.61 333 340 N
R.I(+43.01)CADGVK.L 0.19 6.26 374.6920 29.22 - 34.65 2 1.8E4 31.35 272 278 N Carbamylation
K.DTLTTFDKR.E 0.14 5.93 366.1962 46.86 - 53.06 3 1.7E4 50.33 430 438 N
Y.TLNPAVTILIR.A 1.77 33.59 605.8844 110.58 - 115.73 2 1.6E4 112.36 223 233 N
K.DTLTTFDKR.E 0.16 6.19 548.7795 46.85 - 53.20 2 1.6E4 50.00 430 438 N
R.FGITQAK.V 0.72 10.33 764.4365 43.21 - 49.81 1 1.4E4 46.39 345 351 N
K.ANAAECSMVK(+43.01).D 0.65 9.76 533.7403 35.94 - 42.08 2 1.4E4 38.92 420 429 N Carbamylation
K.LSVAAASEK.T 2.01 48.34 875.4895 35.49 - 41.33 1 1.4E4 37.94 361 369 N
K.TLNVVLK.T 1.56 23.95 786.5167 62.32 - 66.67 1 1.2E4 64.38 370 376 N
R.LSDFLSR.Y 0.80 0.25 419.2274 49.43 - 56.31 2 1.2E4 52.82 334 340 N
K.LAWGLEC(+57.02)K.E 0.22 6.66 488.7531 80.52 - 82.80 2 1.2E4 81.57 288 295 N Carbamidomethylation
K.DTLTTFDK(-.98).R 0.05 5.22 470.2466 49.00 - 54.77 2 1.1E4 51.80 430 437 N Amidation
K.EYSTEITAETGR.I 0.26 6.95 678.8169 50.18 - 55.50 2 1E4 51.81 296 307 N
R.MKITWEK.L 0.40 1.58 468.2455 49.58 - 57.87 2 8.2E3 53.75 316 322 N
R.ADDQVQGYQVAAYVDR.A 0.46 7.35 899.4279 79.09 - 84.27 2 7.4E3 80.91 237 252 N
K.LAWGLECK(+43.01).E 0.14 5.84 481.7504 81.01 - 86.05 2 6.3E3 83.47 288 295 N Carbamylation
K.TLNVVLK.T 0.70 11.23 786.5070 63.58 - 66.35 1 6.2E3 64.51 370 376 N
K.VINMS(+79.97)EEDELLGDK.N Y 0.17 4.60 836.3735 96.62 - 101.39 2 6E3 99.62 39 52 Y Phosphorylation (STY)
K.VINMSEEDELLGDKNILMK.L Y 0.50 8.78 731.0419 114.59 - 116.10 3 5.8E3 115.30 39 57 Y
K.VINMSEEDELLGDK.N Y 0.35 2.85 796.3868 90.14 - 92.68 2 5.4E3 91.54 39 52 Y
K.DTLTTFDK.R 0.16 6.14 470.7388 54.00 - 59.56 2 5E3 56.43 430 437 N
R.ADDQVQGYQVAAYVDR.A 0.37 6.98 599.9544 79.52 - 81.95 3 4.9E3 80.61 237 252 N
R.MKITWEK.L 0.77 9.59 312.5071 54.24 - 58.62 3 4.5E3 56.37 316 322 N
R.IGEDAAVR.M 0.01 3.89 415.7257 31.44 - 42.01 2 4.5E3 34.49 308 315 N
K.FIYMITK.A 1.48 20.68 915.5089 83.44 - 86.34 1 4.4E3 84.96 413 419 N
R.LSDFLSR.Y 0.45 8.34 837.4495 68.61 - 71.40 1 4.1E3 69.68 334 340 N
F.ASLEQNNHWR.I 0.05 5.41 627.8069 37.75 - 44.87 2 3.7E3 42.21 262 271 N
K.L(+43.01)SVAAASEK.T 0.06 5.46 459.7471 57.94 - 66.69 2 3.7E3 61.05 361 369 N Carbamylation
F.ASLEQNNHWR.I 0.01 5.18 418.8731 37.62 - 41.81 3 3.5E3 39.33 262 271 N
R.MKITWEK.L 0.03 5.28 468.2603 54.00 - 58.93 2 2.9E3 56.61 316 322 N
K.LAWGLECK.E 0.15 6.17 919.4722 86.63 - 92.59 1 2.7E3 89.34 288 295 N
R.LQIVFASLEQNNHWR.I 0.50 7.81 927.9796 113.54 - 118.61 2 2.6E3 116.21 257 271 N
K.D(+43.01)HIHQHADS(+79.97)R.E 0.37 7.31 446.8507 27.67 - 29.14 3 1.7E3 28.10 189 198 N Carbamylation; Phosphorylation (STY)
R.F(+43.01)GITQAK.V 0.02 5.39 404.2245 70.28 - 74.77 2 1.7E3 72.10 345 351 N Carbamylation
R.F(+43.01)GITQAK.V 0.30 6.66 807.4354 68.16 - 73.12 1 1.5E3 70.94 345 351 N Carbamylation
K.T(+43.01)LNVVLK.T 0.43 8.50 415.2624 91.94 - 94.21 2 1.2E3 92.91 370 376 N Carbamylation
K.VINMSEEDELLGDK.N Y 0.04 1.57 796.3770 91.11 - 96.60 2 1.1E3 94.13 39 52 N
K.D(+43.01)HIHQHADS(+79.97)R.E 0.49 7.88 669.7739 27.29 - 29.07 2 836.3 28.00 189 198 N Carbamylation; Phosphorylation (STY)
R.LQIVFASLEQNNHWR.I 0.41 0.14 927.9519 113.68 - 119.09 2 590.2 115.25 257 271 N
total 49 peptides